nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
您当前所在位置: 首页> 文献列表> 中医药治疗慢性萎缩性胃炎随机对照试验的系统评价
2015, 02, v.38 143-147+152
中医药治疗慢性萎缩性胃炎随机对照试验的系统评价
基金项目(Foundation): 国家自然科学基金(81160431)
邮箱(Email):
DOI:
发布时间: 2015-02-15
出版时间: 2015-02-15
移动端阅读
摘要:

目的系统、全面分析评价半夏泻心汤及其加减方治疗慢性萎缩性胃炎的临床疗效和安全性。方法计算机检索CNKI、万方数据库、VIP、CBM、Pubmed、EMbase等数据库,并手工检索相关领域杂志,时间从建库至2014年10月。搜集关于半夏泻心汤及其加减方治疗慢性萎缩性胃炎的随机对照研究,并由2名评价员严格按照纳入和排除标准进行文献筛查,独立选择试验、提取资料和质量评估,并采用Review Manager 5软件进行Meta分析。结果最终纳入7项随机对照试验,共683例患者。Meta分析结果显示,未发现双盲试验。在临床有效性方面,中医半夏泻心汤及其加减组优于西医治疗组[RR=1.33,95%CI(1.21,1.46),P<0.000 01],差异具有统计学意义;半夏泻心汤及其加减联合西医治疗组优于单纯西医治疗组[RR=1.26,95%CI(1.00,1.60),P=0.05],差异具有统计学意义。结论半夏泻心汤及其加减方或联合西医治疗慢性萎缩性胃炎的临床疗效和安全性优于西医治疗组,但由于研究文献均为小样本和高偏倚风险的原始研究,建议今后开展样本量充足、设计合理、执行严格的临床试验进一步评价。

Abstract:

Objective To evaluate the clinical efficacy and safety of Banxia xiexin decoction for treating chronic atrophic gastritis with Meta-analysis. Methods We reviewed studies and data about the randomized controlled trials of Banxia xiexin decoction in treating chronic gastritis from The CNKI database,Wang fang database,VIP database,CBM database,Pubmed database and EMbase database and related Chinese journals since the date of database establishment to 2014. The data were reviewed and analyzed independently by two evaluators with Meta analysis method. Results Seven randomized controlled trials involving 683 patients were included in the Meta-analysis.The Meta-analysis showed the Banxia xiexin decoction was better than the west medicine [RR = 1. 15,95% CI( 1.08,1. 24),P <0. 0001]. There was a statistical significance in total effective rate; Banxia xiexin decoction combined with the west medicine was better than the west medicine [RR = 1. 26,95% CI( 1. 00,1. 60),P = 0. 05].Conclusion Existing evidence suggests that the clinical efficacy and safety of Banxia xiexin decoction or combined with western medicine treatment is superior to western medicine treatment group. However,since the findings from all the reviewed studies were based on small sample,and on high risk clinical trials,it is too early to draw a convincing conclusion about the definite clinical efficacy and safety of Banxia xiexin decoction in treating chronic gastritis. We suggest that further clinical trials with adequate samples,rational design and strict execution be carried out to provide more reliable evidence.

参考文献

[1]中华医学会消化病学分会.中国慢性胃炎共识意见[J].现代消化及介入诊疗,2007,11(1):55-62.

[2]孟静岩.慢性萎缩性胃炎[M].北京:中国医药科技出版社,2003:118-121.

[3]Kui Pers EJ,Klinkenbergknol EC,Vandenbroucke Grauls CM,et al.Roleof Helieobaeter Pyloriin the Pathogenesis of atrophiegastritis[J].Gastroenterolsu PPI,1997,223:28-34.

[4]房静远,刘文忠.中国慢性胃炎共识意见(2012年,上海)[J].中华消化杂志,2013,33(1):5-16.

[5]Moher DB,Jones A.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?[J].Lancet,1998,352(9128):609-613.

[6]Kjaergard LJ,Gluud C.Quality of randomized clinical trials affects estimates of intervention efficacy(abstract).in:VII cochrane colloquium[J].Rome,1999,25(18):19-23.

[7]钟安朴,常建国,周泠.中西医联合治疗慢性胃炎幽门螺杆菌感染的疗效[J].中华医院感染学杂志,2014,(13):3270-3272.

[8]文贤军.半夏泻心汤治疗胃脘痛随机平行对照研究[J].实用中医内科杂志,2013,(11):25-26.

[9]李夏林.半夏泻心汤治疗慢性浅表性胃炎疗效观察[J].中国民族民间医药,2013,22(12):96,98.

[10]柯学,彭俊杰,王砚颖.半夏泻心汤治疗慢性萎缩性胃炎多中心随机平行对照研究[J].实用中医内科杂志,2013,(5):128-129,131.

[11]何玉芳.辨证分型联合西药治疗慢性胃炎随机平行对照研究[J].实用中医内科杂志,2013,(18):31-33.

[12]由丽娜,高璇,热依汗古丽·乌修尔,等.中西医结合治疗脾胃湿热型幽门螺杆菌相关性慢性胃炎的临床观察[J].中国全科医学,2012,15(16):1891-1892.

[13]鲁军.半夏泻心汤加减治疗脾胃湿热型慢性胃炎临床观察[J].实用中医内科杂志,2012,(7):84-85.

[14]曹卉娟,刘建平.系统综述中图表的设计与应用*[J].北京中医药大学学报:中医临床版,2013,1(4):43-49.

[15]吴一龙.必须重视阴性结果的临床研究[J].循证医学,2003,3(1):1-2.

基本信息:

中图分类号:R259

引用信息:

[1]郭红梅,曾韦苹,伊凡,等.中医药治疗慢性萎缩性胃炎随机对照试验的系统评价[J].新疆医科大学学报,2015,38(02):143-147+152.

基金信息:

国家自然科学基金(81160431)

发布时间:

2015-02-15

出版时间:

2015-02-15

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文